These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33111078)

  • 1. CRISPR-Cas9-Based Genome Editing and Cytidine Base Editing in
    Wang Y; Wang Z; Ji Q
    STAR Protoc; 2020 Jun; 1(1):100025. PubMed ID: 33111078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Highly Efficient CRISPR-Cas9-Based Genome Engineering Platform in Acinetobacter baumannii to Understand the H
    Wang Y; Wang Z; Chen Y; Hua X; Yu Y; Ji Q
    Cell Chem Biol; 2019 Dec; 26(12):1732-1742.e5. PubMed ID: 31548010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized CRISPR/Cas9-mediated single nucleotide mutation in adherent cancer cell lines.
    Gao P; Dong X; Wang Y; Wei GH
    STAR Protoc; 2021 Jun; 2(2):100419. PubMed ID: 33870225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas9 and CRISPR-Assisted Cytidine Deaminase Enable Precise and Efficient Genome Editing in Klebsiella pneumoniae.
    Wang Y; Wang S; Chen W; Song L; Zhang Y; Shen Z; Yu F; Li M; Ji Q
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217854
    [No Abstract]   [Full Text] [Related]  

  • 5. Harnessing the Native Type I-F CRISPR-Cas System of Acinetobacter baumannii for Genome Editing and Gene Repression.
    Yao S; Wu X; Li Y; Song Y; Wang C; Zhang G; Feng J
    Int J Antimicrob Agents; 2023 Nov; 62(5):106962. PubMed ID: 37673355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Primary Innate Immune Cells.
    Hildreth AD; Riggan L; O'Sullivan TE
    STAR Protoc; 2020 Dec; 1(3):100113. PubMed ID: 33377009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9-based Genome Editing of Pseudomonas aeruginosa.
    Chen W; Ji Q
    Methods Mol Biol; 2024; 2721():3-12. PubMed ID: 37819511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized electroporation of CRISPR-Cas9/gRNA ribonucleoprotein complex for selection-free homologous recombination in human pluripotent stem cells.
    Xu H; Kita Y; Bang U; Gee P; Hotta A
    STAR Protoc; 2021 Dec; 2(4):100965. PubMed ID: 34825222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing the Native Type I-F CRISPR-Cas System in
    Xu Z; Li Y; Yan A
    STAR Protoc; 2020 Jun; 1(1):100039. PubMed ID: 33111087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An efficient and versatile CRISPR-Cas9 system for genetic manipulation of multi-drug resistant
    McConville TH; Giddins MJ; Uhlemann AC
    STAR Protoc; 2021 Mar; 2(1):100373. PubMed ID: 33733242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome editing in Acinetobacter baumannii through enhanced natural transformation.
    Yilmaz I; Ozbek T
    J Basic Microbiol; 2024 Jun; 64(6):e2300644. PubMed ID: 38412427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized protocol to create deletion in adherent cell lines using CRISPR/Cas9 system.
    Farooq U; Notani D
    STAR Protoc; 2021 Dec; 2(4):100857. PubMed ID: 34746853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Genome-Editing Platform for Drug-Resistant Acinetobacter baumannii Reveals an AdeR-Unrelated Tigecycline Resistance Mechanism.
    Trebosc V; Gartenmann S; Royet K; Manfredi P; Tötzl M; Schellhorn B; Pieren M; Tigges M; Lociuro S; Sennhenn PC; Gitzinger M; Bumann D; Kemmer C
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7263-7271. PubMed ID: 27671072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol for the electroporation of CRISPR-Cas for DNA and RNA targeting in Bos taurus zygotes.
    Biase FH; Schettini G
    STAR Protoc; 2024 Mar; 5(1):102940. PubMed ID: 38460133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome Editing in Klebsiella pneumoniae Using CRISPR/Cas9 Technology.
    Wang Z; Wang Y; Ji Q
    Methods Mol Biol; 2022; 2479():105-117. PubMed ID: 35583735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmable base editing in zebrafish using a modified CRISPR-Cas9 system.
    Qin W; Lu X; Lin S
    Methods; 2018 Nov; 150():19-23. PubMed ID: 30076894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome editing in
    Sinha T; Yazdani SS
    STAR Protoc; 2022 Sep; 3(3):101629. PubMed ID: 36042883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A user-friendly and streamlined protocol for CRISPR/Cas9 genome editing in budding yeast.
    Novarina D; Koutsoumpa A; Milias-Argeitis A
    STAR Protoc; 2022 Jun; 3(2):101358. PubMed ID: 35712010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Manipulation of MRSA Using CRISPR/Cas9 Technology.
    Chen W; Ji Q
    Methods Mol Biol; 2020; 2069():113-124. PubMed ID: 31523770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient CRISPR-Cas9-mediated genome editing for characterization of essential genes in
    Picchi-Constante GFA; Hiraiwa PM; Marek M; Rogerio VZ; Guerra-Slompo EP; Romier C; Zanchin NIT
    STAR Protoc; 2022 Jun; 3(2):101324. PubMed ID: 35496799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.